Search Results - "Veenhof, X."

1219P Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction (G/GEJ) adenocarcinoma: The PANDA study by Chalabi, M., Verschoor, Y.L., Van De Haar, J., van den Berg, J., Kodach, L., van Sandick, J., van Dieren, J., Balduzzi, S., Grootscholten, M.C., Veenhof, X., Hartemink, K., Vollebergh, M., Owers, E., Bartels-Rutten, A., den Hartog-Lievaart, P., van Leerdam, M., Schumacher, T.N., Haanen, J.B.A.G., Voest, E.E.

Get full text

Severity of oEsophageal Anastomotic Leak in patients after oesophagectomy: the SEAL score by Ubels, Sander, Verstegen, Moniek, Klarenbeek, Bastiaan, Bouwense, Stefan, van Berge Henegouwen, Mark, Daams, Freek, van Det, Marc J, Griffiths, Ewen A, Haveman, Jan W, Heisterkamp, Joos, Koshy, Renol, Nieuwenhuijzen, Grard, Polat, Fatih, Siersema, Peter D, Singh, Pritam, Wijnhoven, Bas, Hannink, Gerjon, van Workum, Frans, Rosman, Camiel

“…Abstract Background Anastomotic leak (AL) is a common but severe complication after oesophagectomy. It is unknown how to determine the severity of AL…”
Get full text